Previous 10 | Next 10 |
Bellerophon Therapeutics Inc. (BLPH) is expected to report for Q3 2023
2023-07-25 09:52:47 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Mobileye (NASDAQ: MBLY ) stock is on the move Tuesday after Morgan Stanley analyst Adam Jonas renewed coverage of the driver assistance systems company. With that comes the ...
2023-07-25 09:35:46 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biogen (NASDAQ: BIIB ) layoffs are on the way as the company seeks further profits with its new Alzheimer’s disease drug launch. This has the pharmaceutical company p...
2023-07-25 08:46:32 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bellerophon Therapeutics (NASDAQ: BLPH ) stock is losing value on Tuesday after the clinical-stage therapeutics company was sent a delisting notice . The Listing Qualifi...
2023-06-19 06:00:34 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips One reason we invest in the stock market is that we’re all looking to secure our financial futures. We want to be comfortable in our retirements and provide for our families and even fut...
2023-06-05 13:06:50 ET Gainers: Forza X1 ( FRZA ) +164% . Sono Group ( SEV ) +123% . Chijet Motor Company ( CJET ) +62% . CIRCOR International ( CIR ) +51% . Timber Pharmaceuticals ( TMBR ) +44% . TOP Financial Group ( TOP ...
2023-06-05 10:06:47 ET Gainers: Timber Pharmaceuticals ( TMBR ) +36% . Amedisys ( AMED ) +15% . Rockwell Medical ( RMTI ) +15% . Coeptis Therapeutics ( COEP ) +14% . BiondVax Pharmaceuticals ( BVXV ) +12% . Losers: Bellerophon ...
2023-06-05 08:14:50 ET Bellerophon Therapeutic ( BLPH ) -71% announces top-line data from phase 3 REBUILD clinical trial of INOpulse® for treatment of fibrotic interstitial lung disease. Mallinckrodt MNK -18% to consider filing for bankruptcy again - WSJ. ...
Trial did not meet its primary endpoint related to the change in moderate to vigorous physical activity INOpulse® was safe and well-tolerated, consistent with the overall safety profile demonstrated in Phase 2 and other INOpulse® programs in PH-COPD and PH-Sarcoidosis Co...
2023-05-19 10:04:48 ET Gainers: Lucy Scientific Discovery ( LSDI ) +51% . Bioventus ( BVS ) +44% . Mallinckrodt ( MNK ) +28% . 180 Life Sciences ( ATNF ) +28% . Stereotaxis ( STXS ) +25% . Losers: Enveric Biosciences ( ENVB ...
News, Short Squeeze, Breakout and More Instantly...
Bellerophon Therapeutics Inc. Company Name:
BLPH Stock Symbol:
NASDAQ Market:
Bellerophon Therapeutics Inc. Website:
3D Systems Corporation (DDD) is expected to report $-0.11 for Q1 2024 ZW Data Action Technologies Inc. (CNET) is expected to report for Q1 2024 Celularity Inc. (CELU) is expected to report for Q1 2023 DMK Pharmaceuticals Corporation (DMKPQ) is expected to report for Q1 2024 Atlant...
ADDvantage Technologies Group Inc. (AEYGQ) is expected to report for Q1 2024 ContraFect Corporation (CFRXQ) is expected to report for Q1 2024 American Clean Resources Group Inc (ACRG) is expected to report for Q1 2024 Atlantic Lithium Ltd Ord Fully Paid (ALLIF) is expected to report f...
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...